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Aims: The advantages of in situ autologous vein grafts for long infrainguinal arterial reconstructions are the tapered 
conduit, minimising size mismatch at proximal and distal anastomoses, and the possibility of using small sized veins with 
good results. Unfortu~ately, in about 30% of legs the ipsilateral saphenous vein is inadequate r ndering in situ bypass 
grafting impossible. To profit from a valveless autologous vein graft in these cases we routinely performed ex situ 
valvulotomy after harvesting the contralateral saphenous vein or good quality segments of the ipsilateral saphenous 
vein. 
Methods: The ex situ valvulotomy was performed under angioscopic guidance using a flushing-type Mill's 
valvulotome. 
Results: Fifty non reversed grafts in 46 patients entered a prospective surveillance program. Primary and primary-assisted 
patency rates at 2 years were 68% and 82% respectively, early graft thrombosis 2%, late stenosis 8% and major amputation 
rate with a patent graft 6%. No technique related problems were noticed. 
Conclusion: Angioscopy guided valvulotomy was safe and simple and allowed good quality control of the veins. The 
presented results in this study are comparable toother ecently reported series of in situ bypass. The clinical use of small 
flexible endoscopes allows a safe and atraumatic valvulotomy and simultaneous quality control of autologous vein 
grafts. 
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Introduction 
There have been numerous reports of excellent results 
for the in situ bypass as an infrainguinal arterial 
conduit. However, clinical advantages for the in situ 
technique compared to the conventional reversed 
method could only be demonstrated for small sized 
veins. ~ Considering the fact that 30-40% of patients do 
not have an adequate, uninterrupted ipsilateral saphe- 
nous vein for in situ bypass grafting and to profit from 
a valveless, tapered conduit we learned to use veins 
non-reversed. ~ The non-reversed technique combines 
advantages of the in situ technique together with the 
possibility of using good quality saphenous vein 
segments from different locations. Vein quality is 
probably the most important factor in achieving ood 
long term results. 2'3 
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Patients and Methods 
All patients undergoing autogenous non-reversed 
infrainguinal bypass from 1989 to 1992 were reviewed. 
In situ bypasses were excluded from this study. Life- 
table graft patency was calculated using the criteria of 
the Ad Hoc Committee on Reporting Standards for 
Lower Extremity Ischaemia. 4 All patients entered a 
routine surveillance program after intervention to 
document problems, using ankle brachial index (ABI) 
measurements and Duplex imaging of the entire graft 
length. 
We usually used the greater saphenous vein from 
the ipsi- or contralateral leg. The veins were conven- 
tionally harvested using discontinuous longitudinally 
orientated incisions. 
The minimum accepted vein diameter after pressure 
controlled ilatation was 3 mm. Valve disruption was 
performed under angioscopic guidance in combina- 
tion with a modified Mill's valvulotome (Mauch Inc., 
Loogstrasse, CH-4142 Mfinchenstein, Switzerland). 
We used a 2.2 mm or 1.4 mm angioscope without 
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flushing channel (Olympus Inc., Zollikon, Switzer- 
land). Imaging was achieved using a video camera 
with a monitor and Xenon light source. Pressure 
controlled dilatation of the vein was achieved by 
connecting the flushing channel of the valvulotome to 
a simple pressure bag infusion system with a maxi- 
mum pressure of 180 mmHg. The valvulotome was 
inserted through the distal end of the harvested vein 
and was carefully advanced to the proximal end of the 
vein, where the angioscope was introduced without a 
sheath. Valvulotomy and inspection of the inner 
surface of the conduit was achieved from proximal to 
distal with the tip of the angioscope following the 
valvulotome. 5 
Fifty bypasses were performed in 46 patients with a 
mean age of 69.6 years (28-88 years). There were 22 
men and 24 women suffering from severe claudication 
in 19%, ischaemic rest pain in 31% and established 
tissue loss in 50%. Diabetes was found in 39%, 
hypertension i  52% and cigarette smoking in 52% of 
the patients. In 80% of the bypasses the distal 
anastomosis was below the knee (Table 1). In six 
patients (six legs, 12%) revision surgery was necessary 
after previous arterial reconstructions on the ipsi- 
lateral eg. All veins were used "non-reversed" and 
were tunnelled extra-anatomically through subcuta- 
neous tissue with exception of bypasses to the 
infrageniculate popliteal and proximal anterior tibial 
artery. In these cases we used an anatomic ourse of 
the grafts through the popliteal fossa. Routine out- 
patient evaluation, including non-invasive laboratory 
graft surveillance using ABI and Duplex, was sched- 
uled before discharge and at 3, 6, 12, 24, 36, 48 etc. 
months postoperatively. All grafts at risk were further 
evaluated by angiography. Stenoses above 80% diam- 
eter reduction were generally corrected by an elective 
surgical procedure or by angioplasty. All procedures 
to maintain graft patency were performed in patent 
grafts and were included in the life-table analysis to 
calculate the primary assisted patency rates. 
Table 1. Distal anastomosis (n = 50) 
Receiving arteries n (%) 
Suprageniculate popliteal rtery 10 (20%) 
Infrageniculate popliteal rtery 18 (36%) 
Tibial arteries 14 (28%) 
Pedal arteries 8 (16%) 
Results 
Fifty operations were performed in 46 patients. There 
were no intraoperative complications. The average 
time of the ex situ venous preparation was 15 min 
(7-25 min). Two patients died within 30 days of 
surgery (4%). One bypass failed on the third post- 
operative day requiring immediate reoperation. The 
cause of failure was a technical problem at the distal 
anastomosis. No significant graft infection was noted. 
Intraoperatively no technical problems related to the 
described angioscopy guided technique were noted. 
Angioscopically detected intraluminal venous defects 
like webs and strands resulted in removal of venous 
segments in four of 50 saphenous veins (8%). 
Postoperative measurements of ABI showed sig- 
nificant improvement ( > 0.15) in all legs with ablation 
or marked improvement in symptoms. During follow 
up, five of 50 grafts (10%) developed significant 
stenoses requiring to be corrected. One tight stenosis 
was found to be related to an end to end anastomosis 
of two vein segments and required surgical correction. 
Major amputation was necessary in three legs (6%) 
with patent grafts due to severe infection of the foot 
(Table 2). Primary graft patency rates at 1 and 2 years 
were 74 and 68% respectively (Fig. 1). Primary assisted 
patency rates after one and two years were 86 and 81% 
respectively (Fig. 2). 
Table 2. Outcome of non reversed bypass (n = 50) 
Outcome n (%) 
Operative mortality (30 days) 
Secondary procedures 
Wound complications 
Major amputation (parent graft) 
Early graft hrombosis (<30 days) 
2 (4%) 
5 (10%) 
3 (6%) 
3 (6%) 
1 (2%) 
Discussion 
A major disadvantage of in situ bypass grafting is the 
dependence on a good quality ipsilateral saphenous 
vein. Vein quality is one of the most important factors 
influencing graft patency. 2'3'6"7 The saphenous vein 
can be interrupted or totally absent especially after 
previous arterial surgery, varicose vein surgery or 
coronary artery bypass grafting. Thirty to forty per- 
cent of our patients do not have a good quality 
ipsilateral saphenous vein, making in situ bypass 
grafting impossible. An advantage of the in situ 
bypass is the tapered conduit, minimising size dis- 
parities at proximal and distal anastomoses. It is 
possible to achieve excellent results even with small 
diameter veins) More theoretical advantages are a 
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Fig. 1. Primary cumulative patency rates in 50 non-reversed bypasses. The number of grafts at risk at each time interval are shown above 
the graph. (---) s.E. > 10%. 
higher flow rate in valvulotomised small sized veins 
and the potential of reversed flow during diastole 
allowing continuous motion of blood. 8"9 Angioscopy 
guided valvulotomy and quality control of the saphe- 
nous vein seem to influence outcome of infrainguinal 
arterial reconstructions. Miller et al. demonstrated 
advantages for angioscopy 10guided in situ bypass 
grafts in a randomised study. Sales reported a high 
sensitivity for angioscopy to detect intraluminal 
defects, making vascular endoscopy a perfect instru- 
ment for intraluminalquality control, u A prospective 
study by Gilbertson et al. showed advantages in the 
detection of residual valve leaflets after valvulotomy 
in comparison to angiography and Duplex sonog- 
raphyJ 2 We gained experience with an angioscopically 
guided technique in in situ bypass grafting using a 
flushing type Mill's valvulotome. 5 Matsumoto et al. 
were the first to report ex situ valvulotomy using an 
angioscope in combination with a Mill's valvulotome 
in 1987.13They used the prepared veins non-reversed. 
To combine the advantages of a valvulotomised vein 
in combination with angioscopy guided quality con- 
trol we developed the described technique of ex situ 
vein preparation. 
A disadvantage of venous valve ablation is the 
necessity for endoluminal manipulations with the 
potential for endothelial trauma. Vaentinnen et al. 
reported a rather disappointing patency rate of 58% 
after 12 months in a series of 63 non-reversed grafts. 14 
For valvulotomy he turned his grafts inside out to get 
visual control for valve excision; This cumbersome 
technique possibly caused structural damage to the 
vein wall. Beard published results of 85 fully mobil- 
ised, non-reversed grafts with patency rates similar to 
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Fig. 2. Primary assisted patency rates in 50 non-reversed bypasses. The number of grafts at risk at each time interval are shown above the 
graph. (---) S.E. > 10%. 
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those of modern  in situ series, us ing a Hall valve 
stripper for bl ind valvulotomy. ~5 We combined small 
sized angioscopes with an atraumatic modi f ied Mill 's 
f lushing valvulotome. In our experience the 1.4 mm 
angioscope was the instrument of choice as the 2.2 mm 
instrument seemed to be too large, especially for small 
diameter veins. All ex situ prepared veins were used 
non reversed to achieve opt imal  size-match at the 
anastomoses. The presented pr imary  and pr imary  
assisted patency rates are comparable to other recently 
reported series of in situ bypass  grafting, 16 as were the 
early graf t  thrombosis and subsequent graft stenosis 
rates. 
In conclusion, angioscopical ly gu ided "ex situ" vein 
preparat ion allows the creation of a valveless conduit  
that can be used either reversed or non-reversed. The 
procedure permits a high vein util isation rate. Visual 
control of the va lvu lo tomy improves qual ity contro l  
reduces the learning curve and ameliorates the "teach- 
ing effect" dur ing bypass surgery. 
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